R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
Back to search
Official data from USPTO
DELIVEREL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DELIVEREL
ST13
US500000088656821Class
1, 3, 5, 40
Filing
88656821
Registration
6641823
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/29/2022
Trademark type
Word
Nice classes
1, 3, 5, 40
Filing date
10/16/2019
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
04/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Minato-ku, Tokyo, JP
Examiner
OAKES, ANNA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
F. C. (pessoa física)
Representatives
Suzanne M. Hengl BAKER BOTTS L.L.P.
Technical classification
Nice Classes
Class 1Class 3Class 5Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for scientific purposesother than for medical or veterinary use; industrial chemicals; Chemicals for use in industry and science; chemical compositions for developingprinting and enlarging photographs; plant growth regulating preparations; fertilizers; Fatty acids used in the manufacture of pharmaceutical and cosmetic products; Biochemicalsliposomes used in the manufacture of pharmaceutical and cosmetic products; Chemicals additivesliposomes for use in the manufacture of pharmaceutical and cosmetic products; Biochemicalspolyclonal antibodies and monoclonal antibodies for in vitro scientific or research use; Biochemicalspolyclonal antibodies and monoclonal antibodies used in analyzing and detecting certain toxins or diseases for laboratory or research use; anti cancer nucleic acid for laboratory use; anti aging nucleic acid for laboratory use; anti-inflammatory nucleic acid for laboratory use; Biomedical compoundsanti cancer peptide substrates used in analyzing and detecting certain toxins for laboratory use; Biomedical compoundsanti aging peptide substrates used in analyzing and detecting certain toxins for laboratory use; Biomedical compoundsanti-inflammatory peptide substrates used in analyzing and detecting certain toxins for laboratory use; Biomedical compoundsanti cancer compounds used in analyzing and detecting certain toxins for laboratory use; Biomedical compoundsanti aging compounds used in analyzing and detecting certain toxins for laboratory use; anti-inflammatory compounds for laboratory use; Biomedical compoundspeptides used in analysis of angiogenesis for laboratory useother than for medical or veterinary use; cells for laboratory research and scientific useother than for medical or veterinary use; Biochemicalsliposome use for transfection of cells for scientific or research use; Chemical reagentsother than for medical or veterinary purposes
Class 3
Cosmetics; skin soap; bath soap; deodorant soap; dishwasher detergents; laundry detergents; detergents for household use; dentifrices; fragrances and perfumery; essential oils for flavoring food and beverages; incense
Class 5
Drug delivery agents in the form of dissolvable filmscoatings for tablets and capsules composed of liposomes that facilitate the delivery of pharmaceutical preparations and nucleotides; Drug delivery agents in the form of capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of microcapsules composed of liposomes for the delivery of pharmaceutical preparations and nucleotides; Drug delivery agents in the form of dissolvable filmscoatings for tablets and capsules composed of liposome preparations for use in the delivery and release of pharmaceutical preparations; Drug delivery agents in the form of dissolvable filmscoatings for tablets and capsules composed of liposome reagents for transfection of cellsonly for medical and veterinary use; dietary supplements; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; dietary supplements for animals; Drug delivery agents in the form of dissolvable filmscoatings for tablets and capsules composed of antibodies for use in disease testing and pathology diagnosis
Class 40
Processing of liposome pharmaceutical preparations composed of nucleotides for use in manufacture; processing of liposome preparations composed of nucleotides for use in manufacture; processing of pharmaceutical preparations for drug delivery system composed of liposomes for delivering nucleotides for use in manufacture; processing of microcapsules for drug delivery system composed of liposomes for delivering nucleotides for use in manufacture; processing of chemicals for drug delivery system composed of liposomes for delivering nucleotides for use in manufacture; custom manufacture and processing of pharmaceuticals and chemicals for others; custom manufacture and processing of cosmetics and soaps for others
Publications
History of USPTO decisions and trademark events.
39 publications found
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/07/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/07/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/30/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/30/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2021
PUBO
PUBLISHED FOR OPPOSITION
09/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/18/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/02/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/30/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/24/2021
GNRT
NON-FINAL ACTION E-MAILED
05/24/2021
CNRT
NON-FINAL ACTION WRITTEN
05/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/26/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/01/2021
GNSL
LETTER OF SUSPENSION E-MAILED
02/01/2021
CNSL
SUSPENSION LETTER WRITTEN
02/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/22/2021
DOCK
ASSIGNED TO EXAMINER
08/31/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/23/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/23/2020
CNSI
SUSPENSION INQUIRY WRITTEN
07/23/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/18/2020
ALIE
ASSIGNED TO LIE
06/29/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/05/2019
CNSL
SUSPENSION LETTER WRITTEN
12/05/2019
DOCK
ASSIGNED TO EXAMINER
12/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/20/2019
NWAP
NEW APPLICATION ENTERED
10/19/2019
Continuous trademark protection
Get notified about every new filing that threatens DELIVEREL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.